As Stericycle (SRCL) Shares Declined, Advent International Has Cut Its Holding by $8.98 Million; United Therapeutics Del (UTHR) Holder Armistice Capital Has Boosted Stake

May 25, 2018 - By Hazel Jackson

Stericycle, Inc. (NASDAQ:SRCL) Logo

Advent International Corp decreased its stake in Stericycle Inc (SRCL) by 47.42% based on its latest 2017Q4 regulatory filing with the SEC. Advent International Corp sold 134,000 shares as the company’s stock declined 13.72% with the market. The hedge fund held 148,604 shares of the basic industries company at the end of 2017Q4, valued at $10.10 million, down from 282,604 at the end of the previous reported quarter. Advent International Corp who had been investing in Stericycle Inc for a number of months, seems to be less bullish one the $5.41B market cap company. The stock decreased 0.32% or $0.2 during the last trading session, reaching $63.25. About 356,403 shares traded. Stericycle, Inc. (NASDAQ:SRCL) has declined 27.78% since May 25, 2017 and is downtrending. It has underperformed by 39.33% the S&P500.

Armistice Capital Llc increased its stake in United Therapeutics Corp Del (UTHR) by 33.33% based on its latest 2017Q4 regulatory filing with the SEC. Armistice Capital Llc bought 50,000 shares as the company’s stock declined 21.89% with the market. The institutional investor held 200,000 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $29.59M, up from 150,000 at the end of the previous reported quarter. Armistice Capital Llc who had been investing in United Therapeutics Corp Del for a number of months, seems to be bullish on the $4.56 billion market cap company. The stock decreased 0.79% or $0.83 during the last trading session, reaching $104.73. About 157,556 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 23.69% since May 25, 2017 and is downtrending. It has underperformed by 35.24% the S&P500.

More notable recent Stericycle, Inc. (NASDAQ:SRCL) news were published by: Globenewswire.com which released: “Stericycle, Inc. Reports Results for the First Quarter 2018” on May 03, 2018, also Seekingalpha.com with their article: “Stericycle, Inc. 2018 Q1 – Results – Earnings Call Slides” published on May 03, 2018, Seekingalpha.com published: “Stericycle: Looks To Have Turned The Corner” on May 15, 2018. More interesting news about Stericycle, Inc. (NASDAQ:SRCL) were released by: Seekingalpha.com and their article: “Stericycle Muddling Through Difficulties” published on May 22, 2018 as well as Globenewswire.com‘s news article titled: “Stericycle Declares Dividend On Mandatory Convertible Preferred Stock” with publication date: May 05, 2018.

Investors sentiment decreased to 0.7 in 2017 Q4. Its down 0.19, from 0.89 in 2017Q3. It dived, as 75 investors sold SRCL shares while 177 reduced holdings. 50 funds opened positions while 126 raised stakes. 76.99 million shares or 1.32% less from 78.02 million shares in 2017Q3 were reported. Markel Corporation holds 232,000 shares or 0.3% of its portfolio. Guardian Life Insurance Of America holds 0% or 276 shares in its portfolio. Parallax Volatility Advisers LP has invested 0% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL). Bb&T Securities Ltd Liability Corp has invested 0.02% in Stericycle, Inc. (NASDAQ:SRCL). Old Mutual Customised Solutions (Proprietary) Limited owns 700 shares for 0% of their portfolio. Amundi Pioneer Asset Mngmt reported 178,976 shares. Lpl Financial holds 0.01% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL) for 24,179 shares. Johnson Fin Group Inc reported 5 shares or 0% of all its holdings. Swiss Savings Bank stated it has 0.02% in Stericycle, Inc. (NASDAQ:SRCL). Employees Retirement System Of Ohio reported 39,034 shares. Ftb Advsrs holds 0% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL) for 130 shares. Rmb Mngmt Lc reported 9,150 shares. Bancshares, a Missouri-based fund reported 5,978 shares. Toth Financial Advisory reported 0% in Stericycle, Inc. (NASDAQ:SRCL). New Mexico Educational Retirement Board holds 0.02% or 8,190 shares in its portfolio.

Since March 1, 2018, it had 1 buying transaction, and 1 sale for $211,208 activity. Brown Thomas D had sold 13,210 shares worth $837,118 on Wednesday, May 16.

Among 16 analysts covering Stericycle (NASDAQ:SRCL), 6 have Buy rating, 2 Sell and 8 Hold. Therefore 38% are positive. Stericycle had 58 analyst reports since August 14, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $108.0 target in Friday, September 15 report. The stock has “Sell” rating by RBC Capital Markets on Monday, June 26. BMO Capital Markets maintained the stock with “Market Perform” rating in Friday, May 4 report. Wedbush maintained the stock with “Neutral” rating in Monday, May 2 report. The rating was upgraded by Robert W. Baird on Tuesday, February 13 to “Hold”. Imperial Capital maintained the shares of SRCL in report on Thursday, May 26 with “In-Line” rating. As per Friday, October 23, the company rating was downgraded by Oppenheimer. Jefferies maintained the shares of SRCL in report on Friday, November 10 with “Buy” rating. The firm has “Sell” rating given on Tuesday, October 10 by Robert W. Baird. RBC Capital Markets maintained the shares of SRCL in report on Wednesday, October 11 with “Sell” rating.

Analysts await Stericycle, Inc. (NASDAQ:SRCL) to report earnings on August, 2. They expect $1.13 earnings per share, down 1.74% or $0.02 from last year’s $1.15 per share. SRCL’s profit will be $96.71M for 13.99 P/E if the $1.13 EPS becomes a reality. After $1.21 actual earnings per share reported by Stericycle, Inc. for the previous quarter, Wall Street now forecasts -6.61% negative EPS growth.

Among 12 analysts covering United Therapeutics (NASDAQ:UTHR), 2 have Buy rating, 3 Sell and 7 Hold. Therefore 17% are positive. United Therapeutics had 35 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Sector Perform” rating given on Wednesday, July 29 by RBC Capital Markets. Jefferies maintained United Therapeutics Corporation (NASDAQ:UTHR) on Sunday, August 13 with “Sell” rating. As per Sunday, July 30, the company rating was maintained by Oppenheimer. As per Thursday, February 22, the company rating was maintained by Credit Suisse. The firm has “Underweight” rating by Barclays Capital given on Thursday, May 3. The firm has “Neutral” rating by Ladenburg Thalmann given on Friday, April 29. The firm has “Neutral” rating by H.C. Wainwright given on Wednesday, June 15. The company was downgraded on Thursday, January 19 by Standpoint Research. The stock of United Therapeutics Corporation (NASDAQ:UTHR) has “Equal-Weight” rating given on Friday, February 26 by Barclays Capital. The company was maintained on Friday, July 28 by H.C. Wainwright.

Since March 14, 2018, it had 0 insider buys, and 10 insider sales for $26.79 million activity.

More notable recent United Therapeutics Corporation (NASDAQ:UTHR) news were published by: Nasdaq.com which released: “Mid-Morning Market Update: Markets Open Higher; Sprint And T-Mobile To Merge In $26 Billion Deal” on April 30, 2018, also Bizjournals.com with their article: “Md. biotech to be acquired by New Jersey pharmaceutical goliath” published on May 08, 2018, Streetinsider.com published: “Pfizer to pay $23.85 million to settle US co-payment kickback probe” on May 24, 2018. More interesting news about United Therapeutics Corporation (NASDAQ:UTHR) were released by: 247Wallst.com and their article: “Why SteadyMed Shares Are Skyrocketing” published on April 30, 2018 as well as Nasdaq.com‘s news article titled: “SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial Results” with publication date: May 15, 2018.

Investors sentiment increased to 1.14 in 2017 Q4. Its up 0.15, from 0.99 in 2017Q3. It increased, as 26 investors sold UTHR shares while 112 reduced holdings. 53 funds opened positions while 105 raised stakes. 40.90 million shares or 1.42% less from 41.49 million shares in 2017Q3 were reported. Citadel Advisors Ltd Company holds 0% in United Therapeutics Corporation (NASDAQ:UTHR) or 21,230 shares. Fil Limited invested 0.26% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Tiaa Cref Management Limited Liability reported 0.01% in United Therapeutics Corporation (NASDAQ:UTHR). Cornerstone Capital Liability Corp reported 137,508 shares. The New York-based Jane Street Group Ltd Liability Co has invested 0% in United Therapeutics Corporation (NASDAQ:UTHR). Canada Pension Plan Investment Board accumulated 59,192 shares. Orrstown Incorporated has invested 0.01% in United Therapeutics Corporation (NASDAQ:UTHR). Gemmer Asset Mngmt Ltd Liability Co stated it has 117 shares or 0.01% of all its holdings. Millennium Ltd Company has 246,734 shares for 0.05% of their portfolio. Daiwa Secs Group Incorporated has invested 0% in United Therapeutics Corporation (NASDAQ:UTHR). Synovus Finance holds 0.01% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 5,615 shares. Systematic Fincl Management Lp reported 0.04% in United Therapeutics Corporation (NASDAQ:UTHR). Moreover, Northcoast Asset Mngmt Limited Co has 0.17% invested in United Therapeutics Corporation (NASDAQ:UTHR). First Allied Advisory Svcs owns 0.03% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 5,677 shares. National Asset Management holds 1,952 shares.

Stericycle, Inc. (NASDAQ:SRCL) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>